SRPT vs TRINI
Sarepta Therapeutics Inc (SRPT) versus Trinity Capital Inc. 7.875% Notes Due 2029 (TRINI) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Trinity Capital Inc. 7.875% Notes Due 2029 (TRINI) common stock listed on NASDAQ.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
TRINI does not have a complete income-statement cache yet.
SRPT currently screens at market cap $2.34B. TRINI currently screens at market cap $0.
Not investment advice. Open the SRPT and TRINI stock pages for the full models.
Not investment advice.